Sympathetic ophthalmia following diode laser cyclophotocoagulation

Abdullah Albahlal, Hassan Al Dhibi, Sami Al Shahwan, Rajiv Khandekar, Deepak P. Edward

Research output: Contribution to journalArticle

Abstract

Background: Sympathetic ophthalmia is a rare form of bilateral uveitis that develops following an ocular penetrating injury to one eye. Several cases of sympathetic ophthalmia have been reported after non-penetrating cyclodestructive procedures including Nd: YAG and diode laser cyclophotocoagulation (CPC) but information on inciting factors and outcome is limited. In this case series we investigated the inciting factors, clinical features, course and outcome of six patients who developed sympathetic ophthalmia after diode CPC. Methods: Six patients who developed sympathetic ophthalmia after diode CPC were identified from the King Khaled Eye Specialist Hospital uveitis database between 2008 and 2013. The medical records of these patients were reviewed for demographic information, ocular history, diode laser parameters, clinical presentation, treatment and outcome. Results: Six patients were diagnosed with sympathetic ophthalmia following treatment with diode laser CPC, an incidence of 0.001% during the study period. Two patients had a history of accidental trauma and all patients had undergone at least one ocular surgery that included a variety of procedures. At presentation, two patients had predominantly posterior segment findings in the sympathising eye, one patient had only anterior segment findings and the rest had panuveitis. All patients were treated with topical and systemic corticosteroids and/or immunosupressive therapy that resulted in complete resolution of inflammation and return to baseline vision in the sympathising eye within 2-48 months of treatment. Conclusions: Sympathetic ophthalmia after diode CPC is rare and is seen in patients with a history of intraocular surgery with or without previous trauma. Early recognition of sympathetic ophthalmia and aggressive management with immunosuppressive therapy results in good outcomes for these patients.

Original languageEnglish (US)
Pages (from-to)1101-1106
Number of pages6
JournalBritish Journal of Ophthalmology
Volume98
Issue number8
DOIs
StatePublished - 2014

Fingerprint

Sympathetic Ophthalmia
Semiconductor Lasers
Uveitis
Panuveitis
Eye Injuries
Solid-State Lasers
Wounds and Injuries
Therapeutics
Immunosuppressive Agents
Medical Records

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

Albahlal, A., Al Dhibi, H., Al Shahwan, S., Khandekar, R., & Edward, D. P. (2014). Sympathetic ophthalmia following diode laser cyclophotocoagulation. British Journal of Ophthalmology, 98(8), 1101-1106. https://doi.org/10.1136/bjophthalmol-2013-304257

Sympathetic ophthalmia following diode laser cyclophotocoagulation. / Albahlal, Abdullah; Al Dhibi, Hassan; Al Shahwan, Sami; Khandekar, Rajiv; Edward, Deepak P.

In: British Journal of Ophthalmology, Vol. 98, No. 8, 2014, p. 1101-1106.

Research output: Contribution to journalArticle

Albahlal, A, Al Dhibi, H, Al Shahwan, S, Khandekar, R & Edward, DP 2014, 'Sympathetic ophthalmia following diode laser cyclophotocoagulation', British Journal of Ophthalmology, vol. 98, no. 8, pp. 1101-1106. https://doi.org/10.1136/bjophthalmol-2013-304257
Albahlal, Abdullah ; Al Dhibi, Hassan ; Al Shahwan, Sami ; Khandekar, Rajiv ; Edward, Deepak P. / Sympathetic ophthalmia following diode laser cyclophotocoagulation. In: British Journal of Ophthalmology. 2014 ; Vol. 98, No. 8. pp. 1101-1106.
@article{f4415e98e8b0481abbd2e92201b3c3ee,
title = "Sympathetic ophthalmia following diode laser cyclophotocoagulation",
abstract = "Background: Sympathetic ophthalmia is a rare form of bilateral uveitis that develops following an ocular penetrating injury to one eye. Several cases of sympathetic ophthalmia have been reported after non-penetrating cyclodestructive procedures including Nd: YAG and diode laser cyclophotocoagulation (CPC) but information on inciting factors and outcome is limited. In this case series we investigated the inciting factors, clinical features, course and outcome of six patients who developed sympathetic ophthalmia after diode CPC. Methods: Six patients who developed sympathetic ophthalmia after diode CPC were identified from the King Khaled Eye Specialist Hospital uveitis database between 2008 and 2013. The medical records of these patients were reviewed for demographic information, ocular history, diode laser parameters, clinical presentation, treatment and outcome. Results: Six patients were diagnosed with sympathetic ophthalmia following treatment with diode laser CPC, an incidence of 0.001{\%} during the study period. Two patients had a history of accidental trauma and all patients had undergone at least one ocular surgery that included a variety of procedures. At presentation, two patients had predominantly posterior segment findings in the sympathising eye, one patient had only anterior segment findings and the rest had panuveitis. All patients were treated with topical and systemic corticosteroids and/or immunosupressive therapy that resulted in complete resolution of inflammation and return to baseline vision in the sympathising eye within 2-48 months of treatment. Conclusions: Sympathetic ophthalmia after diode CPC is rare and is seen in patients with a history of intraocular surgery with or without previous trauma. Early recognition of sympathetic ophthalmia and aggressive management with immunosuppressive therapy results in good outcomes for these patients.",
author = "Abdullah Albahlal and {Al Dhibi}, Hassan and {Al Shahwan}, Sami and Rajiv Khandekar and Edward, {Deepak P.}",
year = "2014",
doi = "10.1136/bjophthalmol-2013-304257",
language = "English (US)",
volume = "98",
pages = "1101--1106",
journal = "British Journal of Ophthalmology",
issn = "0007-1161",
publisher = "BMJ Publishing Group",
number = "8",

}

TY - JOUR

T1 - Sympathetic ophthalmia following diode laser cyclophotocoagulation

AU - Albahlal, Abdullah

AU - Al Dhibi, Hassan

AU - Al Shahwan, Sami

AU - Khandekar, Rajiv

AU - Edward, Deepak P.

PY - 2014

Y1 - 2014

N2 - Background: Sympathetic ophthalmia is a rare form of bilateral uveitis that develops following an ocular penetrating injury to one eye. Several cases of sympathetic ophthalmia have been reported after non-penetrating cyclodestructive procedures including Nd: YAG and diode laser cyclophotocoagulation (CPC) but information on inciting factors and outcome is limited. In this case series we investigated the inciting factors, clinical features, course and outcome of six patients who developed sympathetic ophthalmia after diode CPC. Methods: Six patients who developed sympathetic ophthalmia after diode CPC were identified from the King Khaled Eye Specialist Hospital uveitis database between 2008 and 2013. The medical records of these patients were reviewed for demographic information, ocular history, diode laser parameters, clinical presentation, treatment and outcome. Results: Six patients were diagnosed with sympathetic ophthalmia following treatment with diode laser CPC, an incidence of 0.001% during the study period. Two patients had a history of accidental trauma and all patients had undergone at least one ocular surgery that included a variety of procedures. At presentation, two patients had predominantly posterior segment findings in the sympathising eye, one patient had only anterior segment findings and the rest had panuveitis. All patients were treated with topical and systemic corticosteroids and/or immunosupressive therapy that resulted in complete resolution of inflammation and return to baseline vision in the sympathising eye within 2-48 months of treatment. Conclusions: Sympathetic ophthalmia after diode CPC is rare and is seen in patients with a history of intraocular surgery with or without previous trauma. Early recognition of sympathetic ophthalmia and aggressive management with immunosuppressive therapy results in good outcomes for these patients.

AB - Background: Sympathetic ophthalmia is a rare form of bilateral uveitis that develops following an ocular penetrating injury to one eye. Several cases of sympathetic ophthalmia have been reported after non-penetrating cyclodestructive procedures including Nd: YAG and diode laser cyclophotocoagulation (CPC) but information on inciting factors and outcome is limited. In this case series we investigated the inciting factors, clinical features, course and outcome of six patients who developed sympathetic ophthalmia after diode CPC. Methods: Six patients who developed sympathetic ophthalmia after diode CPC were identified from the King Khaled Eye Specialist Hospital uveitis database between 2008 and 2013. The medical records of these patients were reviewed for demographic information, ocular history, diode laser parameters, clinical presentation, treatment and outcome. Results: Six patients were diagnosed with sympathetic ophthalmia following treatment with diode laser CPC, an incidence of 0.001% during the study period. Two patients had a history of accidental trauma and all patients had undergone at least one ocular surgery that included a variety of procedures. At presentation, two patients had predominantly posterior segment findings in the sympathising eye, one patient had only anterior segment findings and the rest had panuveitis. All patients were treated with topical and systemic corticosteroids and/or immunosupressive therapy that resulted in complete resolution of inflammation and return to baseline vision in the sympathising eye within 2-48 months of treatment. Conclusions: Sympathetic ophthalmia after diode CPC is rare and is seen in patients with a history of intraocular surgery with or without previous trauma. Early recognition of sympathetic ophthalmia and aggressive management with immunosuppressive therapy results in good outcomes for these patients.

UR - http://www.scopus.com/inward/record.url?scp=84905036706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905036706&partnerID=8YFLogxK

U2 - 10.1136/bjophthalmol-2013-304257

DO - 10.1136/bjophthalmol-2013-304257

M3 - Article

VL - 98

SP - 1101

EP - 1106

JO - British Journal of Ophthalmology

JF - British Journal of Ophthalmology

SN - 0007-1161

IS - 8

ER -